 | • レポートコード：MRC23Q35916 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の臨床試験用CRO市場について調査・分析し、世界の臨床試験用CRO市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル）、用途別セグメント分析（製薬、バイオ製薬、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Labcorp、IQVIA、Parexel、Syneos Health、PRA Health Sciences、PPD、ICON、MedPace、Wuxi AppTecなどが含まれています。 世界の臨床試験用CRO市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、臨床試験用CRO市場規模を推定する際に考慮しました。本レポートは、臨床試験用CROの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、臨床試験用CROに関するビジネス上の意思決定に役立てることを目的としています。 ・臨床試験用CRO市場の概要 - 臨床試験用CROのタイプ別セグメント - 世界の臨床試験用CRO市場規模：タイプ別分析（フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル） - 臨床試験用CROの用途別セグメント - 世界の臨床試験用CRO市場規模：用途別分析（製薬、バイオ製薬、その他） - 世界の臨床試験用CRO市場規模予測（2018年-2029年） ・臨床試験用CRO市場の成長トレンド - 臨床試験用CROの地域別市場規模（2018年-2029年） - 臨床試験用CRO市場ダイナミクス - 臨床試験用CROの業界動向 - 臨床試験用CRO市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル - 世界の臨床試験用CROのタイプ別市場規模（2018年-2023年） - 世界の臨床試験用CROのタイプ別市場規模（2024年-2029年） ・用途別セグメント：製薬、バイオ製薬、その他 - 世界の臨床試験用CROの用途別市場規模（2018年-2023年） - 世界の臨床試験用CROの用途別市場規模（2024年-2029年） ・臨床試験用CROの地域別市場規模 - 北米の臨床試験用CRO市場規模（2018年-2029年） - アメリカの臨床試験用CRO市場規模（2018年-2029年） - ヨーロッパの臨床試験用CRO市場規模（2018年-2029年） - アジア太平洋の臨床試験用CRO市場規模（2018年-2029年） - 中国の臨床試験用CRO市場規模（2018年-2029年） - 日本の臨床試験用CRO市場規模（2018年-2029年） - 韓国の臨床試験用CRO市場規模（2018年-2029年） - インドの臨床試験用CRO市場規模（2018年-2029年） - オーストラリアの臨床試験用CRO市場規模（2018年-2029年） - 中南米の臨床試験用CRO市場規模（2018年-2029年） - 中東・アフリカの臨床試験用CRO市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Labcorp、IQVIA、Parexel、Syneos Health、PRA Health Sciences、PPD、ICON、MedPace、Wuxi AppTec ・アナリストの観点/結論 ・調査方法とデータソース |
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
Highlights
The global CRO in Clinical Trials market was valued at US$ 47210 million in 2022 and is anticipated to reach US$ 81290 million by 2029, witnessing a CAGR of 9.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRO in Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO in Clinical Trials.
The CRO in Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRO in Clinical Trials market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRO in Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Segment by Application
Pharmaceutical
Bio-pharm
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRO in Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Phase I Trial
1.2.3 Phase II Trial
1.2.4 Phase III Trial
1.2.5 Phase IV Trial
1.3 Market by Application
1.3.1 Global CRO in Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Bio-pharm
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRO in Clinical Trials Market Perspective (2018-2029)
2.2 CRO in Clinical Trials Growth Trends by Region
2.2.1 Global CRO in Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CRO in Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2024-2029)
2.3 CRO in Clinical Trials Market Dynamics
2.3.1 CRO in Clinical Trials Industry Trends
2.3.2 CRO in Clinical Trials Market Drivers
2.3.3 CRO in Clinical Trials Market Challenges
2.3.4 CRO in Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRO in Clinical Trials Players by Revenue
3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2018-2023)
3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRO in Clinical Trials Revenue
3.4 Global CRO in Clinical Trials Market Concentration Ratio
3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2022
3.5 CRO in Clinical Trials Key Players Head office and Area Served
3.6 Key Players CRO in Clinical Trials Product Solution and Service
3.7 Date of Enter into CRO in Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRO in Clinical Trials Breakdown Data by Type
4.1 Global CRO in Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2024-2029)
5 CRO in Clinical Trials Breakdown Data by Application
5.1 Global CRO in Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CRO in Clinical Trials Market Size (2018-2029)
6.2 North America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CRO in Clinical Trials Market Size by Country (2018-2023)
6.4 North America CRO in Clinical Trials Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRO in Clinical Trials Market Size (2018-2029)
7.2 Europe CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CRO in Clinical Trials Market Size by Country (2018-2023)
7.4 Europe CRO in Clinical Trials Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRO in Clinical Trials Market Size (2018-2029)
8.2 Asia-Pacific CRO in Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region (2018-2023)
8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRO in Clinical Trials Market Size (2018-2029)
9.2 Latin America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CRO in Clinical Trials Market Size by Country (2018-2023)
9.4 Latin America CRO in Clinical Trials Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRO in Clinical Trials Market Size (2018-2029)
10.2 Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country (2018-2023)
10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Detail
11.1.2 Labcorp Business Overview
11.1.3 Labcorp CRO in Clinical Trials Introduction
11.1.4 Labcorp Revenue in CRO in Clinical Trials Business (2018-2023)
11.1.5 Labcorp Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA CRO in Clinical Trials Introduction
11.2.4 IQVIA Revenue in CRO in Clinical Trials Business (2018-2023)
11.2.5 IQVIA Recent Development
11.3 Parexel
11.3.1 Parexel Company Detail
11.3.2 Parexel Business Overview
11.3.3 Parexel CRO in Clinical Trials Introduction
11.3.4 Parexel Revenue in CRO in Clinical Trials Business (2018-2023)
11.3.5 Parexel Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Detail
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health CRO in Clinical Trials Introduction
11.4.4 Syneos Health Revenue in CRO in Clinical Trials Business (2018-2023)
11.4.5 Syneos Health Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Detail
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2018-2023)
11.5.5 PRA Health Sciences Recent Development
11.6 PPD
11.6.1 PPD Company Detail
11.6.2 PPD Business Overview
11.6.3 PPD CRO in Clinical Trials Introduction
11.6.4 PPD Revenue in CRO in Clinical Trials Business (2018-2023)
11.6.5 PPD Recent Development
11.7 ICON
11.7.1 ICON Company Detail
11.7.2 ICON Business Overview
11.7.3 ICON CRO in Clinical Trials Introduction
11.7.4 ICON Revenue in CRO in Clinical Trials Business (2018-2023)
11.7.5 ICON Recent Development
11.8 MedPace
11.8.1 MedPace Company Detail
11.8.2 MedPace Business Overview
11.8.3 MedPace CRO in Clinical Trials Introduction
11.8.4 MedPace Revenue in CRO in Clinical Trials Business (2018-2023)
11.8.5 MedPace Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Detail
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2018-2023)
11.9.5 Wuxi AppTec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details